| abstract |
The invention discloses a medicine for treating tuberculosis, which belongs to the field of medicine. The present application proves that cannabidiol can significantly inhibit the symptoms of tuberculosis caused by Mycobacterium tuberculosis infection through infection experiments at the level of cells and animals, and has a significant inhibitory effect on tuberculosis caused by drug-resistant tuberculosis bacteria. Compared with clinically used anti-tuberculosis drugs isoniazid INH and bedaquiline BDQ, cannabidiol can not only inhibit tuberculosis infection, but also effectively maintain the body's inflammatory immune balance and inhibit the damage of excessive inflammatory response to the body. It has good clinical application prospects for anti-tuberculosis or other anti-infective diseases. |